Retail News

J&J/Pfizer Selling OTC Zantac

Bloomberg News 10/12/2006

J&J and Pfizer have agreed to sell the U.S. rights to the over-the-counter version of Zantac to Boehringer Ingelheim.

MORE ON THIS STORY...

MORE RETAIL NEWS HEADLINES...

Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!